Fauci says Henry Ford hydroxychloroquine study was 'flawed'

July 31, 2020, 4:04 PM

Dr. Anthony Fauci is joining a chorus of medical voices in questioning a recent study by Henry Ford Health System that found hydroxychloroquine beneficial for treating Covid-19.

Fauci said during a congressional hearing Friday that the study that found hydroxychloroquine cut the disease's death rate was “flawed," according to MLive. A number of researchers have also published critiques of the research, CNN reported this week.

Fauci, an infectious diseases director at the National Institutes of Health, expressed these concerns: 

“The Henry Ford Hospital study that was published was a non-controlled, retrospective cohort study that was confounded by a number of issues including the fact that many people who received hydroxychloroquine were also receiving cortical steroids, which we know from another study gives a clear benefit in reducing deaths with advanced disease. ...

"It's not a randomized placebo controlled trial. ... You can peer review something that is a bad study."

Trump tweeted support for the study after the results came out early last month.

Other large studies have shown the drug provides no benefits to Covid-19 patients. The FDA last month revoked its emergency use authorization.

Read more:  MLive

Leave a Comment:

Photo Of The Day